Details of the Drug Reposition

General Information of This Drug (ID: DM0HSJK)

Drug Name
FF-10501-01   DM0HSJK
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic myelogenous leukaemia DIS0301E 2A20.0 Phase 1/2 [1]
Myelodysplastic syndrome DISYHNUI 2A37 Phase 1/2 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 1/2 [1]
Haematological malignancy DISCDP7W 2B33.Y Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02193958) Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies. U.S. National Institutes of Health.